Keep knowledgeable with free updates
Merely signal as much as the Non-public fairness myFT Digest — delivered on to your inbox.
Blackstone and Omers have every put multibillion-dollar healthcare companies corporations up on the market, as non-public fairness teams search to dump their investments in a push to return money to traders, in line with folks acquainted with the matter.
Non-public fairness large Blackstone has employed advisers to work on a sale of its majority stake in medical health insurance software program supplier HealthEdge, hoping to clinch a deal that values the corporate at greater than $2.5bn, three folks stated.
In the meantime, Omers, one among Canada’s largest pension funds, can be working with advisers to promote Premise Well being, which operates one of many greatest direct-access care networks within the US, in search of a valuation of about $2bn, the folks added.
The 2 public sale processes come as non-public fairness teams gear as much as exit a wave of investments within the healthcare sector and past, after excessive rates of interest constrained sponsor-backed offers lately.
Blackstone and Omers each declined to remark. HealthEdge and Premise didn’t instantly reply to requests for remark.
Investments in 2,700 healthcare corporations had been held by buyout funds for six years or extra as of final November, up from 2,100 corporations 5 years earlier, placing the sector on a footing for “an imminent enhance in sponsor exits” in 2025, Bain & Firm predicted in a report final yr.
The folks cautioned that each sale processes have been at an early stage and may not end in offers, because the house owners may resolve to carry on to their investments. Each corporations would in all probability obtain curiosity from different non-public fairness teams, they added.
Blackstone final examined curiosity in HealthEdge in 2022, however the sale course of didn’t end in a deal. HealthEdge acquired a minority funding from Philippe Laffont’s hedge fund Coatue Administration in 2021, valuing the group at about $2bn.
HealthEdge, which in line with one of many folks generated between $100mn and $120mn in earnings final yr, gives novel software program for well being insurers to modernise their techniques, which eases the method behind designing healthcare plans and making choices about claims.
Premise, which was based in 1964, has via a collection of acquisitions grown to grow to be one of many greatest direct-access care networks within the US, working 800 wellness centres in 46 states to fulfill the wants of greater than 2,500 employers signed as much as its plans.
Each gross sales will mark worthwhile exits for the non-public fairness teams if accomplished. Omers first backed Premise in 2018 in a deal price simply over $1bn together with debt, whereas Blackstone purchased a majority stake in HealthEdge in 2020 valuing the enterprise at about $700mn.
